Humanin

Benefits

About Humanin

Humanin belongs to a small but growing class of mitochondrial-derived peptides — bioactive molecules encoded directly in mitochondrial DNA rather than the nuclear genome. Discovered in 2001 by Nishimoto and colleagues, it was isolated from surviving neurons in the brain of an Alzheimer's disease patient. That origin story set the stage for two decades of research into its neuroprotective and anti-aging potential. The peptide is just 24 amino acids long, but it packs a surprising amount of biological activity. In cell culture and animal models, humanin protects neurons from amyloid-beta toxicity, reduces oxidative stress, and inhibits programmed cell death through multiple pathways. It directly binds the pro-apoptotic protein BAX, preventing it from puncturing mitochondrial membranes. It also interacts with IGFBP-3 to block IGF-1-independent apoptosis, and it activates STAT3 signaling through a trimeric receptor complex. Circulating humanin levels decline with age, which has prompted speculation that it plays a role in the aging process itself. Mouse studies show that humanin administration extends healthspan metrics and improves insulin sensitivity. A 2020 study in Aging found that humanin-treated mice showed better cognitive performance, improved metabolic markers, and reduced inflammatory signaling compared to controls. The HNG analog (S14G substitution) is the most commonly used research variant because it's up to 1,000-fold more potent than native humanin. Most animal dosing studies use HNG rather than the wild-type peptide. That said, humanin research is still overwhelmingly preclinical. No human clinical trials have been completed, and its pharmacokinetic profile in people hasn't been established. The cancer safety question also remains open — humanin's anti-apoptotic effects could theoretically protect tumor cells, and some animal data supports this concern.

Who Should Consider Humanin

• Aging adults interested in mitochondrial-derived peptide research
• Researchers studying neurodegenerative disease and amyloid-beta pathways
• Individuals with metabolic dysfunction exploring preclinical compounds
• People interested in oxidative stress and mitochondrial support

How Humanin Works

Humanin acts through both intracellular and extracellular pathways. On the extracellular side, it binds a trimeric receptor complex composed of CNTFR (ciliary neurotrophic factor receptor), WSX-1, and gp130. This activates the JAK/STAT3 signaling cascade, which upregulates anti-apoptotic gene expression and promotes cell survival. Humanin also engages formyl peptide receptor-like 1 (FPRL1) and FPRL2, triggering ERK 1/2 phosphorylation — a pathway linked to neuroprotection and inflammation modulation. Inside the cell, humanin directly binds BAX, a pro-apoptotic BCL-2 family member. This interaction prevents BAX from translocating to the mitochondrial outer membrane, blocking the formation of pores that would release cytochrome c and trigger the apoptotic cascade. It also binds to tBID, another pro-apoptotic protein, preventing the BAX/BID oligomerization that amplifies mitochondrial membrane permeabilization. A third pathway involves IGFBP-3. Humanin binds IGFBP-3 and prevents it from inducing apoptosis through its IGF-1-independent cell death program. Interestingly, this same IGFBP-3 interaction accelerates humanin's plasma clearance — analogs that don't bind IGFBP-3 (like HNGF6A) circulate longer. At the mitochondrial level, humanin localizes to lysosomal membranes and enhances chaperone-mediated autophagy. It also activates the PI3K/AKT pathway, promoting mitochondrial biogenesis and improving respiratory chain efficiency.

What to Expect

Dosing Protocol

Note: Humanin is a 24-amino acid peptide encoded within the 16S ribosomal RNA gene of mitochondrial DNA. It was first discovered in 2001 from the occipital lobe of an Alzheimer's patient. It's one of several mitochondrial-derived peptides (MDPs), placing it in the same family as MOTS-c. The most studied analog is HNG (S14G-Humanin), which is roughly 1,000x more potent than native humanin in cell-based assays. Nearly all data comes from in vitro and animal models. There are no completed human clinical trials.

How to Inject Humanin

Reconstitute with bacteriostatic water — add slowly along the vial wall, don't spray directly onto the powder. For a 5 mg vial with 2 mL BAC water, each 0.1 mL delivers 0.25 mg. Swirl gently until dissolved; don't shake. Inject subcutaneously into the abdominal area or upper thigh. Rotate injection sites. Use a 29-31 gauge insulin syringe. Administer in the morning or early afternoon on an empty stomach.

Cycling Protocol

Pharmacokinetics

Side Effects

Human side-effect data for humanin doesn't exist because no clinical trials have been completed. In animal studies, the peptide has been generally well-tolerated with no major adverse effects reported at standard research doses. However, several theoretical concerns deserve attention. Humanin's anti-apoptotic mechanism — particularly its inhibition of BAX — could protect cancer cells from programmed death. Some mouse studies have shown that systemically administered humanin promoted tumor progression in triple-negative breast cancer models. This is the single biggest safety flag in the current literature. There's also evidence that sustained humanin overexpression can impair growth and reproductive function in animals, likely through its antagonistic relationship with the GH/IGF-1 axis. Mild injection-site reactions (redness, swelling) are possible with subcutaneous administration.

Contraindications

Drug Interactions

Storage & Stability

Molecular Profile

Related Peptides

MOTS-c

Metabolic

SS-31 (Elamipretide)

Anti-Aging

Epithalon

Anti-Aging

NAD+

Anti-Aging

GHK-Cu

Anti-Aging

References

1. Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives (Biology 2023)PubMed 38132360
2. Pharmacokinetics and Tissue Distribution of Humanin and Its Analogues in Male Rodents (Endocrinology 2009)PubMed 23836030
3. The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan (Aging 2020)PubMed 32575074
4. Humanin and Alzheimer's disease: The beginning of a new field (BBA General Subjects 2022)PubMed 34626746
5. Humanin decreases mitochondrial membrane permeability by inhibiting the membrane association and oligomerization of Bax and Bid proteins (JBC 2017)PubMed 29265109